Finding the molecular switches behind new infectious diseases
Google DeepMind ● Covered by 3 sources
Researchers at Cambridge are using an AI tool called Co-Scientist to identify molecular mechanisms that cause severe disease when pathogens jump from animals to humans. Professor Clare Bryant's lab tested the tool on flu research and found it could narrow experimental focus from candidate proteins down to specific amino acids in six months instead of the typical two to three years. If the AI-guided approach identifies the correct targets, this could accelerate the discovery of intervention points to prevent zoonotic disease severity in humans.
Why it matters
Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.
